Arteris, Inc.

Listed Company

AIPCIK 0001667011NasdaqEmerging GrowthSemiconductors & Related DevicesDelawareFY ends Dec 31

Period

FY 2025

Revenue

$70.58M

Net Income

$-34.75M

Total Assets

$115.03M

Equity

$-14.63M

Shares Out

46.17M

Op. Cash Flow

$6.73M

AIP$31.02+215.56% · past yearDBEQ Basic

Daily closing prices

Business

Arteris is a leading provider of semiconductor system intellectual property (IP), including Network-on-Chip (NoC) interconnect and SoC Integration Automation software solutions that manage on-chip data movement across chiplets and System-on-Chip semiconductors. The company offers configurable interconnect IP products (FlexGen, FlexNoC, FlexWay, Ncore, CodaCache), SoC integration automation software (Magillem, CSRCompiler), and hardware security verification solutions (Cycuity), delivered under license, support, maintenance, and royalty business models. Arteris serves semiconductor designers and OEMs across aerospace and defense, automotive, communications, consumer electronics, enterprise computing, and industrial markets globally, with an installed base of over four billion production SoCs.

Summary from 10-K filed 2026-02-12

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total revenue	71	58	54	50	38
Cost of revenue	7	6	5	4	4
Gross profit	64	52	49	46	34
Research and development	50	45	45	41	31
Sales and marketing	27	21	21	17	12
General and administrative	20	18	18	16	13
Total operating expenses	97	83	84	75	56
Loss from operations	−33	−32	−35	−29	−22
Interest expense	−193,000	−244,000	−211,000	—	—
Other income (expense), net	3	3	4	1	−474,000
Loss before income taxes and loss from equity method investment	−30	−28	−32	−28	−22
Loss from equity method investment, net of tax	3	3	3	284,000	0
Loss before provision for income taxes	−33	−31	—	—	−22
Provision for income taxes	1	3	2	−417,000	1
Net loss	−35	−34	−37	−27	−23
Net loss per share attributable to common stockholders, basic (in dollars per share)	−0.82	−0.86	−1.03	−0.84	−1.06
Net loss per share attributable to common stockholders, diluted (in dollars per share)	−0.82	−0.86	−1.03	−0.84	−1.06
Weighted average shares used in computing per share amounts, basic (in shares)	42	39	36	33	22
Weighted average shares used in computing per share amounts, diluted (in shares)	42	39	36	33	22

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	34	14	14	37	86
Short-term investments (Note 5)	21	30	27	31	0
Accounts receivable, net of allowance of $73 and $131 as of December 31, 2025, and 2024, respectively	19	21	12	7	14
Prepaid expenses and other current assets	9	5	5	6	7
Total current assets	82	69	58	81	107
Property and equipment, net	4	4	6	4	2
Long-term investments (Note 5)	5	9	12	4	0
Equity method investment	3	6	9	12	0
Operating lease right-of-use assets	4	4	4	2	3
Intangibles, net	2	3	4	5	3
Goodwill	4	4	4	4	3
Other assets	11	8	6	4	3
TOTAL ASSETS	115	106	103	116	120
Accounts payable	340,000	539,000	183,000	572,000	2
Accrued expenses and other current liabilities	19	16	—	—	—
Operating lease liabilities, current	1	917,000	781,000	899,000	961,000
Deferred revenue, current	51	40	32	29	28
Vendor financing arrangements, current	1	1	2	1	833,000
Total current liabilities	73	59	46	44	42
Deferred revenue, noncurrent	44	35	25	22	21
Operating lease liabilities, noncurrent	3	3	4	1	2
Vendor financing arrangements, noncurrent	452,000	594,000	1	448,000	266,000
Deferred income, noncurrent	6	8	9	10	0
Other liabilities	2	2	2	1	2
Total liabilities	130	107	88	78	68
Commitments and contingencies (Note 11)	—	—	—	—	—
Preferred stock, par value of $0.00110,000,000 shares authorized and no shares issued and outstanding as of both December 31, 2025, and 2024	0	0	0	0	0
Common stock, par value of $0.001300,000,000 shares authorized at December 31, 2025, and 2024; 44,268,816 and 40,724,936 shares issued and outstanding at December 31, 2025, and 2024, respectively	44,000	40,000	37,000	34,000	31,000
Additional paid-in capital	157	136	118	104	92
Accumulated other comprehensive income	179,000	135,000	120,000	101,000	−81,000
Accumulated deficit	−172	−137	−103	−66	−39
Total stockholders deficit	−15	−1	15	38	53
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT	115	106	103	116	120

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	3	3	3	2	1
Stock-based compensation	18	16	15	12	6
Pension plan expenses	201,000	163,000	134,000	136,000	109,000
Amortization of deferred income	−1	−1	−1	−391,000	0
Net accretion of discounts on available-for-sale securities	−368,000	−695,000	−893,000	−177,000	0
Other, net	401,000	−9,000	128,000	14,000	−9,000
Accounts receivable, net	1	−9	−5	7	477,000
Prepaid expenses and other assets	−6	−1	−1	202,000	−4
Accounts payable	−191,000	324,000	−389,000	−1	350,000
Accrued expenses and other liabilities	3	3	2	517,000	3
Deferred revenue	20	19	6	830,000	16
Net cash provided by (used in) operating activities	7	−720,000	−16	−7	−814,000
Purchases of property and equipment	−1	−324,000	−2	−1	−808,000
Purchases of available-for-sale securities and other	−30	−37	−48	−35	0
Proceeds from maturities and sales of available-for-sale securities and other	43	38	45	0	—
Net cash provided by investing activities	12	970,000	−5	−37	−1
Principal payments under vendor financing arrangements	−2	−2	−1	−1	−574,000
Proceeds from exercise of stock options	2	890,000	500,000	900,000	600,000
Proceeds from employee stock purchase plan	982,000	538,000	0	—	—
Other financing activities	72,000	59,000	79,000	0	0
Net cash provided by (used in) financing activities	1	−262,000	−3	−4	76
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	20	−12,000	−23	−48	74
Cash paid for taxes	3	2	1	790,000	489,000
Accrued deferred offering costs	522,000	0	—	—	—
Operating lease right-of-use assets exchanged for lease liabilities	1	464,000	3	63,000	0
Purchase of property and equipment through vendor financing	2	546,000	3	2	1

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Arteris, Inc.'s CIK number?

Arteris, Inc.'s SEC CIK number is 0001667011 (1667011). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Arteris, Inc.'s SEC filings?

All of Arteris, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Arteris, Inc. last report earnings?

Arteris, Inc. (AIP) most recently filed an earnings 8-K with the SEC on May 12, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-034102). This is Arteris, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is Arteris, Inc.'s most recent earnings 8-K?

Arteris, Inc.'s latest earnings 8-K (Item 2.02) was filed May 12, 2026 under accession 0001628280-26-034102. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Arteris, Inc.'s latest earnings 8-K →
Look up any company's CIK number →